Invesco’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-215,494
Closed -$1.06M 3877
2025
Q1
$1.06M Buy
215,494
+111,839
+108% +$355K ﹤0.01% 2808
2024
Q4
$305K Buy
103,655
+3,286
+3% +$13.5K ﹤0.01% 3411
2024
Q3
$474K Sell
100,369
-513
-0.5% -$2.31K ﹤0.01% 3257
2024
Q2
$388K Sell
100,882
-893
-0.9% -$4.03K ﹤0.01% 3383
2024
Q1
$544K Buy
101,775
+54,698
+116% +$257K ﹤0.01% 3287
2023
Q4
$201K Buy
47,077
+2,638
+6% +$8.11K ﹤0.01% 3569
2023
Q3
$174K Buy
44,439
+593
+1% +$3.89K ﹤0.01% 3637
2023
Q2
$444K Sell
43,846
-398
-0.9% -$4.21K ﹤0.01% 3298
2023
Q1
$451K Buy
44,244
+11,992
+37% +$137K ﹤0.01% 3314
2022
Q4
$302K Buy
32,252
+633
+2% +$8.93K ﹤0.01% 3504
2022
Q3
$460K Sell
31,619
-1,177
-4% -$17.5K ﹤0.01% 3288
2022
Q2
$434K Buy
32,796
+6,965
+27% +$94.9K ﹤0.01% 3399
2022
Q1
$440K Buy
25,831
+1,041
+4% +$17.7K ﹤0.01% 3463
2021
Q4
$636K Buy
+24,790
New +$773K ﹤0.01% 3284

Other funds holding TSVT

Invesco's TSVT Position: Q2 2025 in Review

Invesco sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 215,494 shares — an estimated $1.06M sold.

Invesco first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $1.06M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Invesco reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 215,494 2seventy bio shares in Q2 2025, an estimated $1.06M.
  • Invesco first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Invesco's 2seventy bio position peaked at $1.06M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.